Switzerland
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.41 B
|
Dec. 31, 2024 | USD 651.30 | 2.02% |
|
Switzerland |
|
2 |
USD 1.24 B
|
Dec. 31, 2023 | USD 46.21 | -3.47% |
|
Switzerland |
|
3 |
USD 479.70 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
|
4 |
USD 93.32 M
|
Dec. 31, 2023 | USD 27.36 | -2.78% |
|
Switzerland |
|
5 |
USD 89.86 M
|
March 31, 2024 | USD 382.54 | -3.00% |
|
Switzerland |
|
6 |
USD 73.88 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
7 |
USD 62.66 M
|
Dec. 31, 2023 | USD 41.59 | -1.07% |
|
Switzerland |
|
8 |
USD 57.83 M
|
Dec. 31, 2023 | USD 62.45 | -2.60% |
|
Switzerland |
|
9 |
USD 51.37 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
10 |
USD 27.57 M
|
Dec. 31, 2023 | USD 74.55 | -2.22% |
|
Switzerland |
|
11 |
USD 8.19 M
|
Dec. 31, 2023 | USD 1.14 K | -1.12% |
|
Switzerland |
|
12 |
USD -203.10 K
|
Dec. 31, 2023 | USD 24.30 | -3.46% |
|
Switzerland |
|
13 |
USD -203.10 K
|
Dec. 31, 2023 | USD 17.87 | -4.83% |
|
Switzerland |
|
14 |
USD -1.39 M
|
Dec. 31, 2023 | USD 5.05 | -4.17% |
|
Switzerland |
|
15 |
USD -7.13 M
|
Dec. 31, 2023 | USD 161.30 | -1.97% |
|
Switzerland |
|
16 |
USD -11.18 M
|
Dec. 31, 2023 | USD 126.21 | -1.33% |
|
Switzerland |
|
17 |
USD -20.43 M
|
Dec. 31, 2023 | USD 3.57 | -5.82% |
|
Switzerland |
|
18 |
USD -26.05 M
|
Dec. 31, 2023 | USD 60.16 | -1.72% |
|
Switzerland |
|
19 |
USD -60.06 M
|
Dec. 31, 2023 | USD 250.45 | -3.26% |
|
Switzerland |
|
20 |
USD -68.06 M
|
Dec. 31, 2023 | USD 43.76 | -1.99% |
|
Switzerland |
|
21 |
USD -86.65 M
|
Dec. 31, 2023 | USD 15.53 | -0.65% |
|
Switzerland |
|
22 |
USD -93.89 M
|
Dec. 31, 2023 | USD 88.99 | -0.28% |
|
Switzerland |
|
23 |
USD -112.54 M
|
Dec. 31, 2023 | USD 1.12 K | -0.26% |
|
Switzerland |
|
24 |
USD -182.67 M
|
Dec. 31, 2023 | USD 13.36 | -0.81% |
|
Switzerland |
|
25 |
USD -240.67 M
|
Dec. 31, 2023 | USD 21.72 | -0.35% |
|
Switzerland |
|
26 |
USD -504.07 M
|
Dec. 31, 2023 | USD 138.90 | -2.86% |
|
Switzerland |
|
27 |
USD -5.03 B
|
Dec. 31, 2023 | USD 333.72 | 0.27% |
|
Switzerland |
|
28 |
USD -11.74 B
|
Dec. 31, 2024 | USD 104.72 | -0.12% |
|
Switzerland |
The Healthcare company in Switzerland with the highest Net Cash Used Provided By Financing Activities is Lonza Group AG (Swiss Stock Exchange: LONN.SW) at USD 1.41 B.
The Healthcare company in Switzerland with the lowest Net Cash Used Provided By Financing Activities is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD -11.74 B.
The top 10 Healthcare companies in Switzerland by Net Cash Used Provided By Financing Activities are Lonza Group AG, Sandoz Group AG, MoonLake Immunotherapeutics, PolyPeptide Group AG, Ypsomed Holding AG, ADC Therapeutics SA, CRISPR Therapeutics AG, Bachem Holding AG, AC Immune SA and Medartis Holding AG.
The bottom 10 Healthcare companies in Switzerland by Net Cash Used Provided By Financing Activities are Novartis AG, Roche Holding AG, Straumann Holding AG, DocMorris AG, medmix AG, Siegfried Holding AG, Galenica AG, Aevis Victoria SA, Basilea Pharmaceutica AG and Tecan Group AG.